Javascript must be enabled to continue!
Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
View through CrossRef
Backround: The reversation of NMBA (neuromuscular blocking agents) prevents numerous postoperative complications, increases quality of recovery and decreases the time, expenditure spending in hospital. The choice of medicine used to reverse NMBA depends considered as a key fators to gain the best outcome and to avoid the side effects.
Aim: To evaluate the postoperative effect on muscle relaxation reversal and side effects of sugammadex 2 mg/kg versus the combination of neostigmine and atropine sulfate in the living kidney donors.
MethodS: A randomised controlled trial on 70 patients undergoing living kidney donation surgery were allocated to 2 groups. Patients in group I (SUGA) were reversed with sugammadex 2 mg/kg and in group II (NEO/ATR) with the combination of neostigmine and atropine sulfat.
Results: With 35 patients in each group, the study results showed that after 3 mintutes of reversal patients reaching TOF value ≥ 0.9 in group SUGA is 91.4%, after 5 minutes 100% of patients in group SUGA reached TOF value ≥ 0.9 . In group NEO/ATR after 3 minutes 28.6% patients reached TOF ≥ 0.9 and 40% patients reached TOF≥ 0.9 after 5 minutes. The difference in percentage of patients reaching TOF ≥ 0.9 after 3 minutes, 5 minutes of reversal between two groups is significant (p<0.05). After 10 minutes, 100% patients in both group got TOF ≥ 0.9. Time to exutubation of group SUGA was 249.43 ± 81.75 seconds and it was 456.29 ± 146.45 seconds in group NEO/ATR. Nausea, bradycardia, and increased phlegm production in group NEO/ATR was 22.9%; 28.5%; 25.7% respectively; while those side effects were not met in group SUGA, the difference was significant (p<0.05).
Conclusion: The muscle relaxation reversal effect of sugammadex was faster than that of neostigmine, the duration TOF ≥ 0.9 and the time to extubation was significantly faster. Sugammadex did not cause hemodynamic changes before and after muscle relaxation reversal, neostigmine resulted in the bradycardia, increased phlegm secreting and other side effects. The renal function after 24 hours postoperatively of two groups was similar.
Scientific Foundation Spiroski (publications)
Title: Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
Description:
Backround: The reversation of NMBA (neuromuscular blocking agents) prevents numerous postoperative complications, increases quality of recovery and decreases the time, expenditure spending in hospital.
The choice of medicine used to reverse NMBA depends considered as a key fators to gain the best outcome and to avoid the side effects.
Aim: To evaluate the postoperative effect on muscle relaxation reversal and side effects of sugammadex 2 mg/kg versus the combination of neostigmine and atropine sulfate in the living kidney donors.
MethodS: A randomised controlled trial on 70 patients undergoing living kidney donation surgery were allocated to 2 groups.
Patients in group I (SUGA) were reversed with sugammadex 2 mg/kg and in group II (NEO/ATR) with the combination of neostigmine and atropine sulfat.
Results: With 35 patients in each group, the study results showed that after 3 mintutes of reversal patients reaching TOF value ≥ 0.
9 in group SUGA is 91.
4%, after 5 minutes 100% of patients in group SUGA reached TOF value ≥ 0.
9 .
In group NEO/ATR after 3 minutes 28.
6% patients reached TOF ≥ 0.
9 and 40% patients reached TOF≥ 0.
9 after 5 minutes.
The difference in percentage of patients reaching TOF ≥ 0.
9 after 3 minutes, 5 minutes of reversal between two groups is significant (p<0.
05).
After 10 minutes, 100% patients in both group got TOF ≥ 0.
9.
Time to exutubation of group SUGA was 249.
43 ± 81.
75 seconds and it was 456.
29 ± 146.
45 seconds in group NEO/ATR.
Nausea, bradycardia, and increased phlegm production in group NEO/ATR was 22.
9%; 28.
5%; 25.
7% respectively; while those side effects were not met in group SUGA, the difference was significant (p<0.
05).
Conclusion: The muscle relaxation reversal effect of sugammadex was faster than that of neostigmine, the duration TOF ≥ 0.
9 and the time to extubation was significantly faster.
Sugammadex did not cause hemodynamic changes before and after muscle relaxation reversal, neostigmine resulted in the bradycardia, increased phlegm secreting and other side effects.
The renal function after 24 hours postoperatively of two groups was similar.
Related Results
Half-dose sugammadex with neostigmine versus full-dose sugammadex for reversal of rocuronium in laparoscopic bariatric surgery
Half-dose sugammadex with neostigmine versus full-dose sugammadex for reversal of rocuronium in laparoscopic bariatric surgery
Abstract
Background
Sugammadex reverses rocuronium more effective than neostigmine during deeper neuromuscular blockade levels. Relying upon the high cost of sugammadex we hypothes...
Economic Impact of Improving Patient Safety Using Sugammadex for Routine Reversal of Neuromuscular Blockade in Spain
Economic Impact of Improving Patient Safety Using Sugammadex for Routine Reversal of Neuromuscular Blockade in Spain
Abstract
Background: Neuromuscular blocking (NMB) agents are often administered to facilitate tracheal intubation and prevent patient movement during surgical procedures re...
Economic Impact of Improving Patient Safety Using Sugammadex for Routine Reversal of Neuromuscular Blockade in Spain
Economic Impact of Improving Patient Safety Using Sugammadex for Routine Reversal of Neuromuscular Blockade in Spain
Abstract
Background
Neuromuscular blocking (NMB) agents are often administered to facilitate tracheal intubation and prevent patient movement during surgical procedures re...
THE IMPORTANCE OF SUGAMMADEX AT POSTOPERATIVE RESIDUAL NEUROMUSCULAR BLOCK
THE IMPORTANCE OF SUGAMMADEX AT POSTOPERATIVE RESIDUAL NEUROMUSCULAR BLOCK
Introduction: postoperative residual neuromuscular blockade is the postoperative muscle paralysis caused by incomplete or null antagonism of neuromuscular blocking agents. Post-sur...
A Multi-center Study of Intrathecal Neostigmine for Analgesia following Vaginal Hysterectomy
A Multi-center Study of Intrathecal Neostigmine for Analgesia following Vaginal Hysterectomy
Background
Intrathecal neostigmine injection produces analgesia in volunteers and reduces hypotension from intrathecal bupivacaine in animals. Initial clinical trials w...
Neurological symptoms and MRI changes post-sugammadex reversal
Neurological symptoms and MRI changes post-sugammadex reversal
Although sugammadex revolutionized anesthesia with rapid, effective reversal of non-depolarizing neuromuscular blocking agents, post-marketing surveillance identified rare occurren...
Magnesium sulfate and sugammadex: implications for routine practice
Magnesium sulfate and sugammadex: implications for routine practice
Purpose of the review
Magnesium sulfate (MgSO4) enhances neuromuscular blockade; it may accelerate onset, prolong clinical duration, and delay neuromuscular recovery. I...
Sugammadex versus neostigmine in pediatric cancer patients undergoing outpatient surgical procedures
Sugammadex versus neostigmine in pediatric cancer patients undergoing outpatient surgical procedures
Neuromuscular blocking agents (NMBAs) are still required for the pediatric population. Residual neuromuscular block is a common complication in the early postoperative period. The ...

